Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Accenture
UBS
Chinese Patent Office
Boehringer Ingelheim
US Department of Justice
Fuji

Generated: July 17, 2018

DrugPatentWatch Database Preview

Ziconotide acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ziconotide acetate and what is the scope of ziconotide acetate patent protection?

Ziconotide acetate
is the generic ingredient in one branded drug marketed by Jazz Pharms Intl and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ziconotide acetate has six patent family members in four countries.

There is one drug master file entry for ziconotide acetate. One supplier is listed for this compound.
Summary for ziconotide acetate
International Patents:6
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Suppliers / Packagers: 1
Bulk Api Vendors: 26
Patent Applications: 40
DailyMed Link:ziconotide acetate at DailyMed
Pharmacology for ziconotide acetate
Synonyms for ziconotide acetate
08CON001
107452-89-1
148979-96-8
148979-97-9
150770-63-1
7I64C51O16
AKOS015896032
AKOS015994641
AM000832
AN-7501
CHEBI:135912
CHEMBL2103752
Conotoxin MVIIA
Conotoxin MVIIA_Smartox
CTX MVIIA
D01NLB
DRG-0250
FT-0675902
GTPL2536
HS-2032
HSDB 7609
I06-1841
L-Cysteinyl-L-lysylglycyl-L-lysylglycyl-L-alanyl-L-lysyl-L-cysteinyl-L-seryl-L-arginyl-L-leucyl-L-methionyl-L-tyrosyl-L-alpha-aspartyl-L-cysteinyl-L-cysteinyl-L-threonylglycyl-L-seryl-L-cysteinyl-L-arginyl-L-serylglycyl-L-lys
LS-172052
MFCD00145036
MolPort-009-194-186
NCGC00181313-01
o-Conotoxin MVIIA
Omega conotoxin MVIIA
omega-Conopeptide MVIIA (Conus)
Omega-ConopeptideMVIIA (Conus)
omega-Conotoxin M VIIA
omega-Conotoxin M VIIA (reduced), cyclic (1-16),(8-20),(15-25)-tris(disulfide)
omega-conotoxin MVIIA
omega-Conotoxin MVIIA, >=95% (HPLC)
omega-Conotoxin mviia, conus magus
Prialt
Prialt (TN)
SCHEMBL676878
SNX 111
SNX-111
UNII-7I64C51O16
Y-100004
Ziconotide
Ziconotide [USAN:INN]
Ziconotide [USAN]

US Patents and Regulatory Information for ziconotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-001 Dec 28, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-004 Dec 28, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-002 Dec 28, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-003 Dec 28, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ziconotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-003 Dec 28, 2004 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-004 Dec 28, 2004 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-004 Dec 28, 2004 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-002 Dec 28, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ziconotide acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,268,109 Method for reducing pain ➤ Sign Up
7,524,812 Pharmaceutical formulation comprising ziconotide ➤ Sign Up
7,833,973 Pharmaceutical formulations for reducing pain ➤ Sign Up
7,956,030 Method for reducing pain with ziconotide and baclofen ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for ziconotide acetate

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0027 France ➤ Sign Up PRODUCT NAME: ZICONOTIDE; REGISTRATION NO/DATE IN FRANCE: EU/1/04/302/001 DU 20050221; REGISTRATION NO/DATE AT EEC: EU/1/04/302/001-003 DU 20050221
C/GB05/033 United Kingdom ➤ Sign Up PRODUCT NAME: ZICONOTIDE, OPTIONALLY IN THE FORM OF A SALT WITH A PHARMACEUTICALLY ACCEPTABLE ACID, INCLUDING ZICONOTIDE ACETATE; REGISTRATION NO/DATE: EU/1/04/302/001 - 003 20050224
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Farmers Insurance
Queensland Health
Harvard Business School
Cipla
Cerilliant
Accenture
McKesson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.